455 Mission Bay Boulevard South
San Francisco, CA 94158
Biotech and Pharmaceutical
Cairn Biosciences is developing the first technology platform for high throughput screening of disease biology in disease-relevant living cells. By measuring the dynamic behavior of cellular machinery, our live cell high-content screening (LC-HCS) platform pinpoints and measures the diverse aspects of cellular physiology that are perturbed by candidate therapeutics, biological stimuli and disease pathologies. These capabilities will accelerate the pace of early stage discovery of therapeutic compounds, reduce the rate of compound attrition in late stage drug discovery and enable improved predictive toxicology assays to evaluate new chemicals and biological agents for the risks they may pose to human health.
Cancer, Central Nervous System
Clinical Development Stage